Niconico News: Supporting Medical Institutions Moving Towards Relaxed Visitation Rules in Response to the FY2026 Medical Fee Revision

News Highlights

The FY2026 medical fee revision requires medical institutions to address the relaxation of visitation rules. In response, Niconico News reports on initiatives to support medical institutions that are moving towards relaxed visitation. This movement encompasses crucial points in the management and business succession strategies of medical institutions, such as early response to the medical fee revision, maintaining facility standards and dispersing the burden of capital investment through economies of scale, and utilizing tax schemes with an eye towards transitioning to specific medical corporations or social medical corporations.

Perspective from M&A Medical Editorial Department

Support for adapting to the relaxed visitation rules in the FY2026 medical fee revision should be viewed not merely as a relaxation of infection control measures, but as a significant development concerning the business continuity of medical institutions. Particularly, as mid- to long-term management and succession strategies are being questioned with the revision cycle in mind, this keyword “relaxed visitation” needs to be considered not only for improving patient satisfaction but also for securing new revenue streams and efficiently utilizing medical resources. For instance, capital investments such as renovating visitation spaces or introducing online visitation systems, which might be burdensome individually, could potentially allow for the dispersion of investment burdens while maintaining facility standards if the benefits of scale through group formation are realized. Furthermore, when considering a transition to specific medical corporations or social medical corporations, tax schemes that link these investments and system preparations to preferential tax treatment should be explored. Depending on the size of the medical institution and regional characteristics, options such as corporate integration through M&A or collaboration based on functional division should also be considered, requiring strategic responses.

Points Highlighted by This News

• Responding to “relaxed visitation” in the FY2026 medical fee revision will be a key point in the management and succession strategies of medical institutions.
• The effectiveness of group formation, utilizing economies of scale to maintain facility standards and disperse the burden of capital investment, is increasing.
• Utilizing tax schemes with an eye towards transitioning to specific medical corporations and social medical corporations may contribute to improved management efficiency.
• Balancing improved patient satisfaction with the efficient use of medical resources will be key to responding to relaxed visitation.

Practical Questions Arising from This News

• What are the specific benchmarks for capital investment and system development to accommodate relaxed visitation?
• What kind of tax benefits can be expected when considering group formation or corporate transition?
• How will response strategies for relaxed visitation vary depending on regional characteristics and the size of the medical institution?

If You Feel “Should I Consult Too?”

Medical institution managers and successors who feel that the response to relaxed visitation in the FY2026 medical fee revision may directly impact their management and succession strategies, rather than just being a relaxation of infection control, should consider consulting with experts. It is particularly important to quickly grasp the optimal options tailored to your institution’s situation regarding concrete management improvement and business succession measures, such as dispersing capital investment burdens and utilizing tax schemes. M&A brokerage firms offer comprehensive consulting services that take these revision responses into account.

M&A Medical (CentralMedience Inc.) supports the business succession of medical corporations, hospitals, and clinics on a full success fee basis as a certified M&A support institution by the Small and Medium Enterprise Agency. Consultations are handled with strict confidentiality. Free consultation here